DAIICHI SANKYO – Acquiring Xinshengyuan – A Little Step Forward in China Aims at Multiple Objectives!
Daiichi Sankyo’s (DS) announcement to take over Shanghai Xinshengyuan Pharmaceutical Group in China thru its Chinese subsidiary Daiichi Sankyo (China) Holdings Co., Ltd. came as a surprise last week. Xinshengyuan is largely a distributing company which also imported and distributed RBXY products in China. At first sight, DS seems to be taking control over RBXY products in China but the implications of this deal could be manifold and aims at long term objectives.
COMPANIES MENTIONED
DAIICHI SANKYO
DAIICHI SANKYO
